Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21593
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Paschou, S. | en |
dc.contributor.author | Voulgari, P. V. | en |
dc.contributor.author | Vrabie, I. G. | en |
dc.contributor.author | Saougou, I. G. | en |
dc.contributor.author | Drosos, A. A. | en |
dc.date.accessioned | 2015-11-24T19:15:58Z | - |
dc.date.available | 2015-11-24T19:15:58Z | - |
dc.identifier.issn | 0315-162X | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21593 | - |
dc.rights | Default Licence | - |
dc.subject | Adult | en |
dc.subject | Antibodies, Monoclonal/*adverse effects | en |
dc.subject | Antirheumatic Agents/adverse effects | en |
dc.subject | Fertility/*drug effects/physiology | en |
dc.subject | Humans | en |
dc.subject | Infertility/*chemically induced | en |
dc.subject | Male | en |
dc.subject | Reproduction/drug effects/physiology | en |
dc.subject | Spermatogenesis/*drug effects/physiology | en |
dc.subject | Spermatozoa/drug effects/physiology | en |
dc.subject | Spondylitis, Ankylosing/*drug therapy | en |
dc.subject | Tumor Necrosis Factor-alpha/antagonists & inhibitors | en |
dc.title | Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.3899/jrheum.080554 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19040305 | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2009 | - |
heal.abstract | OBJECTIVE: To identify male patients who were treated with infliximab and had fathered healthy newborns during their management. METHODS: We reviewed medical records of men with ankylosing spondylitis (AS) who were followed up at the Rheumatology Outpatients clinic and were treated with infliximab during the period 2001-2007. RESULTS: We identified 4 patients with AS who had fathered 6 healthy children during infliximab treatment. One patient was also treated with small doses of methotrexate. CONCLUSION: Limited data are available concerning the effects of infliximab on semen quality. Our cases provide some evidence or reassurance for male patients treated with the anti-tumor necrosis factor-alpha agent. Further prospective studies are necessary, however, to guide clinicians in decision making. | en |
heal.journalName | J Rheumatol | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License